Hudson Bay Capital Management’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-42,931
Closed -$1.6M 1310
2024
Q4
$1.6M Buy
42,931
+30,431
+243% +$1.42M 0.01% 695
2024
Q3
$625K Sell
12,500
-140,254
-92% -$5.46M ﹤0.01% 712
2024
Q2
$5.3M Buy
+152,754
New +$6.04M 0.02% 361
2024
Q1
Sell
-5,000
Closed -$214K 735
2023
Q4
$214K Sell
5,000
-5,000
-50% -$155K ﹤0.01% 578
2023
Q3
$260K Sell
10,000
-119,963
-92% -$2.49M ﹤0.01% 623
2023
Q2
$3.11M Buy
+129,963
New +$2.24M 0.02% 418
2022
Q4
Sell
-102,300
Closed -$630K 993
2022
Q3
$630K Buy
+102,300
New +$742K 0.01% 880

Other funds holding BHVN

Hudson Bay Capital Management's BHVN Position: Q1 2025 in Review

Hudson Bay Capital Management sold out of Biohaven (BHVN) in Q1 2025, closing a stake of 42,931 shares — an estimated $1.6M sold.

Hudson Bay Capital Management first reported a position in BHVN in Q3 2022 and held it in 7 quarters. The position peaked at $5.3M in Q2 2024. 266 funds tracked by Wall St. Rank hold BHVN as of Q1 2025.

  • Hudson Bay Capital Management reported no remaining Biohaven position as of Q1 2025 after selling out during the quarter.
  • Hudson Bay Capital Management sold 42,931 Biohaven shares in Q1 2025, an estimated $1.6M.
  • Hudson Bay Capital Management first reported a position in Biohaven in Q3 2022 and held it in 7 quarters.
  • Hudson Bay Capital Management's Biohaven position peaked at $5.3M in Q2 2024.
  • 266 funds tracked by Wall St. Rank held Biohaven as of Q1 2025.

Based on Hudson Bay Capital Management's 13F filing for Q1 2025, filed 14 May 2025.